236 related articles for article (PubMed ID: 36613930)
1. Snapshots of ABCG1 and ABCG5/G8: A Sterol's Journey to Cross the Cellular Membranes.
Rezaei F; Farhat D; Gursu G; Samnani S; Lee JY
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613930
[TBL] [Abstract][Full Text] [Related]
2. Structural Analysis of Cholesterol Binding and Sterol Selectivity by ABCG5/G8.
Farhat D; Rezaei F; Ristovski M; Yang Y; Stancescu A; Dzimkova L; Samnani S; Couture JF; Lee JY
J Mol Biol; 2022 Oct; 434(20):167795. PubMed ID: 35988751
[TBL] [Abstract][Full Text] [Related]
3. Picky ABCG5/G8 and promiscuous ABCG2 - a tale of fatty diets and drug toxicity.
Khunweeraphong N; Mitchell-White J; Szöllősi D; Hussein T; Kuchler K; Kerr ID; Stockner T; Lee JY
FEBS Lett; 2020 Dec; 594(23):4035-4058. PubMed ID: 32978801
[TBL] [Abstract][Full Text] [Related]
4. Association of ABCG5 and ABCG8 Transporters with Sitosterolemia.
Bydlowski SP; Levy D
Adv Exp Med Biol; 2024; 1440():31-42. PubMed ID: 38036873
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane Polar Relay Drives the Allosteric Regulation for ABCG5/G8 Sterol Transporter.
Xavier BM; Zein AA; Venes A; Wang J; Lee JY
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228147
[TBL] [Abstract][Full Text] [Related]
6. Metformin and AMP Kinase Activation Increase Expression of the Sterol Transporters ABCG5/8 (ATP-Binding Cassette Transporter G5/G8) With Potential Antiatherogenic Consequences.
Molusky MM; Hsieh J; Lee SX; Ramakrishnan R; Tascau L; Haeusler RA; Accili D; Tall AR
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1493-1503. PubMed ID: 29853564
[TBL] [Abstract][Full Text] [Related]
7. Effects of SNVs in ABCA1, ABCG1, ABCG5, ABCG8, and SCARB1 Genes on Plasma Lipids, Lipoproteins, and Adiposity Markers in a Brazilian Population.
Zago VHS; Scherrer DZ; Parra ES; Vieira IC; Marson FAL; de Faria EC
Biochem Genet; 2022 Apr; 60(2):822-841. PubMed ID: 34505223
[TBL] [Abstract][Full Text] [Related]
8. ABCG5/G8: a structural view to pathophysiology of the hepatobiliary cholesterol secretion.
Zein AA; Kaur R; Hussein TOK; Graf GA; Lee JY
Biochem Soc Trans; 2019 Oct; 47(5):1259-1268. PubMed ID: 31654053
[TBL] [Abstract][Full Text] [Related]
9. Evidence that the adenosine triphosphate-binding cassette G5/G8-independent pathway plays a determinant role in cholesterol gallstone formation in mice.
Wang HH; Li X; Patel SB; Wang DQ
Hepatology; 2016 Sep; 64(3):853-64. PubMed ID: 27014967
[TBL] [Abstract][Full Text] [Related]
10. Structure of the Human Cholesterol Transporter ABCG1.
Skarda L; Kowal J; Locher KP
J Mol Biol; 2021 Oct; 433(21):167218. PubMed ID: 34461069
[TBL] [Abstract][Full Text] [Related]
11. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice.
Wu JE; Basso F; Shamburek RD; Amar MJ; Vaisman B; Szakacs G; Joyce C; Tansey T; Freeman L; Paigen BJ; Thomas F; Brewer HB; Santamarina-Fojo S
J Biol Chem; 2004 May; 279(22):22913-25. PubMed ID: 15044450
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.
Wang HH; Liu M; Portincasa P; Wang DQ
Adv Exp Med Biol; 2020; 1276():105-136. PubMed ID: 32705597
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of cholesterol efflux via ABCG subfamily transporters.
Sun Y; Wang J; Long T; Qi X; Donnelly L; Elghobashi-Meinhardt N; Esparza L; Cohen JC; Xie XS; Hobbs HH; Li X
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34404721
[TBL] [Abstract][Full Text] [Related]
14. ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion.
Graf GA; Yu L; Li WP; Gerard R; Tuma PL; Cohen JC; Hobbs HH
J Biol Chem; 2003 Nov; 278(48):48275-82. PubMed ID: 14504269
[TBL] [Abstract][Full Text] [Related]
15. Abcc6 deficiency in mice leads to altered ABC transporter gene expression in metabolic active tissues.
Ibold B; Faust I; Tiemann J; Gorgels TGMF; Bergen AAB; Knabbe C; Hendig D
Lipids Health Dis; 2019 Jan; 18(1):2. PubMed ID: 30611276
[TBL] [Abstract][Full Text] [Related]
16. ABCG5 and ABCG8: more than a defense against xenosterols.
Patel SB; Graf GA; Temel RE
J Lipid Res; 2018 Jul; 59(7):1103-1113. PubMed ID: 29728459
[TBL] [Abstract][Full Text] [Related]
17. LAL (Lysosomal Acid Lipase) Promotes Reverse Cholesterol Transport In Vitro and In Vivo.
Bowden KL; Dubland JA; Chan T; Xu YH; Grabowski GA; Du H; Francis GA
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1191-1201. PubMed ID: 29599133
[TBL] [Abstract][Full Text] [Related]
18. Role of ABCG1 and other ABCG family members in lipid metabolism.
Schmitz G; Langmann T; Heimerl S
J Lipid Res; 2001 Oct; 42(10):1513-20. PubMed ID: 11590207
[TBL] [Abstract][Full Text] [Related]
19. NPC1L1 and ABCG5/8 induction explain synergistic fecal cholesterol excretion in ob/ob mice co-treated with PPAR-α and LXR agonists.
Srivastava RAK; Cefalu AB; Srivastava NS; Averna M
Mol Cell Biochem; 2020 Oct; 473(1-2):247-262. PubMed ID: 32661772
[TBL] [Abstract][Full Text] [Related]
20. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR.
Khovidhunkit W; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
J Lipid Res; 2003 Sep; 44(9):1728-36. PubMed ID: 12777468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
